Loading clinical trials...
Loading clinical trials...
Comparative Evaluation of Postoperative Pain and Success Rate After Pulpotomy in Mature Permanent Molars Using Biodentine Versus Mineral Trioxide Aggregate (MTA) as Capping Materials: A Randomized Clinical Trial
The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth using Biodentine versus MTA regarding postoperative pain and success rate.
* Patients will be clinically and radiographically examined and their eligibility will be assessed. * Eligible patients will be randomly assigned to one of 2 groups: experimental group (pulpotomy using Biodentine) and the control group (pulpotomy using MTA). * After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam isolation. The pulp tissue will be removed until the level of the orifices of the canals. After hemostasis is achieved, the capping material will be placed. In the experimental group, the capping material is Biodentine while in the control group, the capping material is MTA * The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be permanently restored with composite . A post-operative radiograph will be taken. * The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked to rate their pain level at the specified times. * The patients will be recalled after 6 and 12 months post-operatively.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
No
Start Date
May 1, 2019
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
March 26, 2019
70
ESTIMATED participants
MTA Pulpotomy.
PROCEDURE
Biodentine Pulpotomy
PROCEDURE
Lead Sponsor
Cairo University
NCT07410780
NCT07290049
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07130760